Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Elizabeth Blair

Concepts (341)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell
19
2019
1002
1.730
Why?
Head and Neck Neoplasms
24
2017
972
1.680
Why?
Salivary Gland Neoplasms
5
2019
57
1.490
Why?
Carcinoma, Mucoepidermoid
2
2019
15
1.470
Why?
Chemoradiotherapy
14
2022
290
1.140
Why?
Neoplasm Recurrence, Local
12
2019
1149
1.010
Why?
Oropharyngeal Neoplasms
6
2022
118
0.920
Why?
Antineoplastic Combined Chemotherapy Protocols
19
2022
2240
0.920
Why?
Mouth Neoplasms
7
2018
173
0.800
Why?
Paranasal Sinus Diseases
2
2018
23
0.790
Why?
Gene Rearrangement
2
2019
167
0.770
Why?
Papillomavirus Infections
5
2022
196
0.770
Why?
Neoplasm Grading
1
2019
317
0.710
Why?
Laryngeal Diseases
2
2015
15
0.700
Why?
Nose Diseases
1
2017
10
0.690
Why?
Nose Neoplasms
1
2017
31
0.690
Why?
Maxillary Sinus
2
2018
26
0.660
Why?
Nasal Cavity
1
2017
90
0.660
Why?
Trans-Activators
1
2019
427
0.630
Why?
Paranasal Sinus Neoplasms
1
2016
22
0.610
Why?
Aspergillosis
1
2016
45
0.600
Why?
Cementoma
1
2015
2
0.600
Why?
Mandibular Neoplasms
1
2015
25
0.590
Why?
Sarcoidosis
1
2015
88
0.550
Why?
Papillomaviridae
4
2022
141
0.550
Why?
Laryngeal Neoplasms
5
2017
82
0.540
Why?
Sjogren's Syndrome
3
2009
28
0.510
Why?
Salivary Glands, Minor
2
2009
10
0.500
Why?
Middle Aged
43
2022
24750
0.480
Why?
Aged, 80 and over
21
2020
6383
0.460
Why?
Otolaryngology
1
2012
38
0.450
Why?
Airway Management
1
2012
33
0.450
Why?
Female
51
2022
43278
0.440
Why?
Humans
68
2022
80834
0.420
Why?
Adult
39
2022
25137
0.410
Why?
Placenta
1
2011
196
0.400
Why?
Aged
34
2020
17903
0.390
Why?
Anesthesiology
1
2012
157
0.390
Why?
Quinazolines
4
2012
213
0.390
Why?
Male
48
2022
40407
0.380
Why?
Induction Chemotherapy
6
2022
140
0.380
Why?
Disease-Free Survival
15
2020
1157
0.360
Why?
Neck
2
2020
88
0.340
Why?
Head
2
2020
115
0.330
Why?
Hydroxyurea
9
2012
228
0.330
Why?
Radiotherapy, Intensity-Modulated
5
2016
167
0.320
Why?
Clinical Competence
1
2012
684
0.310
Why?
Radiotherapy Dosage
11
2020
463
0.300
Why?
Warts
2
2019
11
0.300
Why?
Fluorouracil
9
2012
537
0.290
Why?
Tongue Neoplasms
4
2018
51
0.280
Why?
Nasopharyngeal Neoplasms
2
2016
44
0.280
Why?
Diagnosis, Differential
4
2017
1546
0.280
Why?
Alphapapillomavirus
2
2021
38
0.260
Why?
Treatment Outcome
17
2022
7653
0.260
Why?
Antineoplastic Agents
6
2012
2276
0.260
Why?
Neoplasm Staging
12
2016
1872
0.240
Why?
Paclitaxel
5
2022
455
0.240
Why?
Laryngostenosis
1
2021
13
0.230
Why?
Tracheal Stenosis
1
2021
22
0.230
Why?
Carcinoma
2
2016
439
0.220
Why?
Drug Monitoring
1
2022
109
0.220
Why?
Carcinoma, Papillary, Follicular
1
2020
11
0.220
Why?
DNA, Viral
1
2022
275
0.220
Why?
Respiratory System
1
2021
112
0.210
Why?
In Situ Hybridization, Fluorescence
2
2019
356
0.210
Why?
ras Proteins
1
2020
128
0.200
Why?
Smoking
3
2014
544
0.200
Why?
Follow-Up Studies
13
2019
3717
0.200
Why?
Proto-Oncogene Proteins B-raf
1
2020
132
0.200
Why?
Lymph Nodes
2
2016
517
0.200
Why?
Risk Factors
8
2019
5257
0.200
Why?
Retrospective Studies
15
2018
7532
0.200
Why?
Arteries
1
2020
174
0.200
Why?
Practice Guidelines as Topic
2
2017
1043
0.190
Why?
Thyroid Neoplasms
2
2020
431
0.190
Why?
Heterocyclic Compounds
1
2019
15
0.190
Why?
Immunologic Deficiency Syndromes
1
2019
41
0.190
Why?
Young Adult
6
2022
5780
0.190
Why?
Radiation Dosage
1
2020
219
0.190
Why?
Prognosis
9
2022
3603
0.190
Why?
Lip
2
2009
14
0.190
Why?
Bone Cysts, Aneurysmal
1
2018
7
0.190
Why?
Receptors, CXCR4
1
2019
41
0.190
Why?
Combined Modality Therapy
9
2016
1628
0.180
Why?
Precancerous Conditions
2
2016
191
0.180
Why?
Ubiquitin Thiolesterase
1
2018
54
0.180
Why?
Orthodontic Appliances
1
2018
8
0.180
Why?
Dental Alloys
1
2018
7
0.180
Why?
Deglutition
3
2020
69
0.180
Why?
Inflammation
2
2017
795
0.180
Why?
Child
6
2019
6587
0.170
Why?
Glottis
1
2017
9
0.170
Why?
Adolescent
7
2022
8878
0.170
Why?
Bone Marrow
1
2019
401
0.170
Why?
Life Style
1
2018
182
0.160
Why?
Hypopharyngeal Neoplasms
2
2011
15
0.160
Why?
Fibrosis
1
2017
188
0.160
Why?
Prospective Studies
7
2022
3961
0.160
Why?
Transcriptome
1
2020
513
0.160
Why?
Neoplasm Invasiveness
3
2016
512
0.150
Why?
Fibroma, Ossifying
1
2015
5
0.150
Why?
Time Factors
4
2019
5282
0.150
Why?
Anticarcinogenic Agents
1
2016
72
0.150
Why?
Guideline Adherence
1
2017
216
0.150
Why?
Premedication
1
1995
57
0.150
Why?
Pleural Neoplasms
1
2017
171
0.150
Why?
Gene Expression Regulation, Neoplastic
1
2020
1164
0.140
Why?
Cerebellopontine Angle
1
1994
6
0.140
Why?
Ulnar Nerve
1
1994
6
0.140
Why?
Neuroma, Acoustic
1
1994
16
0.140
Why?
Tumor Virus Infections
1
2014
79
0.140
Why?
Predictive Value of Tests
1
2019
1705
0.130
Why?
Maximum Tolerated Dose
3
2012
259
0.130
Why?
Neuromuscular Blocking Agents
1
1994
35
0.130
Why?
Leukoplakia, Oral
1
2013
9
0.130
Why?
Facial Nerve
1
1994
35
0.130
Why?
Aminolevulinic Acid
1
2013
21
0.130
Why?
Anti-Bacterial Agents
2
1999
796
0.130
Why?
Photosensitizing Agents
1
2013
47
0.130
Why?
Carboplatin
3
2022
267
0.130
Why?
Biopsy
4
2009
1150
0.130
Why?
Mouth
2
2011
51
0.120
Why?
Monitoring, Intraoperative
1
1994
141
0.120
Why?
Photochemotherapy
1
2013
96
0.120
Why?
Pain
1
2015
354
0.120
Why?
Radiation-Sensitizing Agents
1
2012
100
0.120
Why?
Education, Medical, Graduate
1
2016
330
0.120
Why?
Deglutition Disorders
2
2011
82
0.120
Why?
Lymph Node Excision
1
2013
196
0.110
Why?
Radiotherapy
2
2011
335
0.110
Why?
Research Design
2
2013
545
0.110
Why?
Survival Analysis
5
2018
1535
0.110
Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.110
Why?
Chemotherapy, Adjuvant
5
2012
445
0.110
Why?
Protein Kinase Inhibitors
1
2016
532
0.110
Why?
Tracheotomy
1
2011
17
0.110
Why?
Organ Preservation
1
2011
71
0.110
Why?
Survival Rate
4
2019
1852
0.110
Why?
Speech
1
2010
72
0.100
Why?
Brain Diseases
1
2011
184
0.100
Why?
Genetic Predisposition to Disease
1
2019
2168
0.100
Why?
Vocal Cords
1
2009
18
0.100
Why?
Airway Obstruction
1
2011
112
0.100
Why?
Agammaglobulinemia
1
2010
21
0.100
Why?
Quality of Life
3
2012
1335
0.100
Why?
Developmental Disabilities
1
2011
176
0.100
Why?
Emergency Medical Services
1
2012
177
0.100
Why?
Vascular Endothelial Growth Factor A
2
2009
368
0.100
Why?
Kaplan-Meier Estimate
4
2013
868
0.090
Why?
Cohort Studies
5
2018
2627
0.090
Why?
Radiotherapy, High-Energy
1
2008
50
0.090
Why?
United States
6
2018
6156
0.090
Why?
Confidence Intervals
4
2018
227
0.090
Why?
Enteral Nutrition
2
2020
103
0.090
Why?
Neck Dissection
4
2010
70
0.090
Why?
Myelitis, Transverse
1
2008
9
0.090
Why?
Submandibular Gland Diseases
1
2008
9
0.090
Why?
Genomics
1
2014
631
0.090
Why?
Neoplasms, Second Primary
1
2011
247
0.090
Why?
Military Personnel
1
2009
76
0.090
Why?
Neoadjuvant Therapy
2
2012
265
0.090
Why?
Neuromyelitis Optica
1
2008
16
0.090
Why?
Skin
1
2012
540
0.090
Why?
Aortic Aneurysm
1
1988
81
0.090
Why?
Fatal Outcome
2
2019
290
0.080
Why?
Risk Assessment
5
2016
2205
0.080
Why?
Taxoids
1
2007
125
0.080
Why?
Sinus Thrombosis, Intracranial
1
2006
11
0.080
Why?
DNA
1
2012
1253
0.080
Why?
Tinnitus
1
2006
19
0.080
Why?
Headache
1
2006
67
0.080
Why?
Incidence
3
2018
1593
0.080
Why?
Prodrugs
2
1996
47
0.080
Why?
Drug Administration Schedule
4
2016
926
0.070
Why?
Infant, Newborn
1
2011
2352
0.070
Why?
Dose-Response Relationship, Drug
3
2019
1991
0.070
Why?
Antibodies, Monoclonal
2
2010
1466
0.070
Why?
Drug Therapy, Combination
3
1999
969
0.070
Why?
Cisplatin
2
2022
559
0.070
Why?
Gastroesophageal Reflux
2
2009
110
0.070
Why?
Pregnancy
1
2011
2717
0.070
Why?
Adenocarcinoma
1
2011
1132
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2017
99
0.070
Why?
Radiotherapy, Adjuvant
3
2010
295
0.060
Why?
Internship and Residency
1
2012
887
0.060
Why?
Tomography, X-Ray Computed
2
2011
2479
0.060
Why?
Remission Induction
2
2016
690
0.060
Why?
Retreatment
2
2012
106
0.060
Why?
Immunohistochemistry
3
2017
1766
0.060
Why?
Pulmonary Surgical Procedures
1
2021
8
0.060
Why?
Alcohol Drinking
2
2018
273
0.060
Why?
Gene Expression Profiling
2
2020
1322
0.060
Why?
Receptor, Endothelin A
1
2021
22
0.060
Why?
Clinical Trials, Phase II as Topic
2
2013
166
0.060
Why?
Endothelial Growth Factors
1
2001
56
0.060
Why?
Respiratory Function Tests
1
2021
145
0.060
Why?
Lymphokines
1
2001
108
0.060
Why?
Constriction, Pathologic
1
2021
208
0.050
Why?
Periodontal Diseases
1
2000
9
0.050
Why?
Lymphoid Tissue
1
2000
55
0.050
Why?
Radiography
2
2014
842
0.050
Why?
Hyperplasia
1
2000
146
0.050
Why?
Bronchoscopy
1
2021
146
0.050
Why?
Antibodies, Monoclonal, Humanized
3
2011
891
0.050
Why?
Disease Progression
2
2017
1430
0.050
Why?
Clindamycin
2
1999
15
0.050
Why?
Cefuroxime
2
1996
3
0.050
Why?
Feasibility Studies
1
2022
729
0.050
Why?
Tonsillectomy
1
1999
27
0.050
Why?
Patient-Centered Care
1
2021
175
0.050
Why?
Carcinoma, Papillary
1
2001
182
0.050
Why?
Benzylamines
1
2019
14
0.050
Why?
Neoplasms, Squamous Cell
1
2019
19
0.050
Why?
Aortic Rupture
2
1990
51
0.050
Why?
Bone Marrow Examination
1
2019
51
0.050
Why?
Patient Care Team
1
2021
260
0.050
Why?
Antibiotic Prophylaxis
1
1999
79
0.050
Why?
Primary Myelofibrosis
1
2019
52
0.050
Why?
Evidence-Based Medicine
1
2021
436
0.050
Why?
Oral Health
1
2018
10
0.050
Why?
Double-Blind Method
3
2016
1829
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
11
0.040
Why?
Myoepithelioma
1
2017
11
0.040
Why?
Metals
1
2018
87
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2017
23
0.040
Why?
Laryngectomy
1
2017
25
0.040
Why?
Surgical Wound Infection
2
1999
183
0.040
Why?
Multivariate Analysis
2
2011
968
0.040
Why?
Parotid Gland
1
2017
33
0.040
Why?
Statistics, Nonparametric
2
2009
312
0.040
Why?
Adenocarcinoma, Clear Cell
1
2017
58
0.040
Why?
Oncogene Proteins, Fusion
1
2017
118
0.040
Why?
Mutation
2
2020
3737
0.040
Why?
Probability
2
2008
346
0.040
Why?
Otitis Media
1
1996
13
0.040
Why?
Translocation, Genetic
1
2017
260
0.040
Why?
Loss of Heterozygosity
1
2016
84
0.040
Why?
Otitis Media with Effusion
1
1995
7
0.040
Why?
Pyrazoles
1
2017
162
0.040
Why?
Analgesics, Opioid
1
2020
373
0.040
Why?
Cutaneous Fistula
1
1995
11
0.040
Why?
Cellulitis
1
1995
22
0.040
Why?
Cephalosporins
1
1995
39
0.040
Why?
Pyridines
1
2017
300
0.040
Why?
Dissection
1
1995
46
0.040
Why?
Magnetic Resonance Imaging
3
2017
3149
0.040
Why?
Human papillomavirus 18
1
2014
15
0.040
Why?
Costs and Cost Analysis
1
1995
149
0.030
Why?
Human papillomavirus 16
1
2014
36
0.030
Why?
Protein Interaction Maps
1
2014
49
0.030
Why?
Sex Factors
1
2018
1046
0.030
Why?
Drug Costs
1
1995
60
0.030
Why?
Hospital Costs
1
1995
99
0.030
Why?
Administration, Oral
1
2016
700
0.030
Why?
Electromyography
1
1994
169
0.030
Why?
Drug Resistance, Neoplasm
1
2017
553
0.030
Why?
Amoxicillin-Potassium Clavulanate Combination
3
1999
4
0.030
Why?
Clavulanic Acids
3
1999
4
0.030
Why?
Societies, Medical
1
2017
558
0.030
Why?
Amoxicillin
3
1999
14
0.030
Why?
DNA Copy Number Variations
1
2014
174
0.030
Why?
Multicenter Studies as Topic
1
2013
146
0.030
Why?
Electric Stimulation
1
1994
365
0.030
Why?
Age Factors
1
2018
1842
0.030
Why?
Rabbits
1
1994
706
0.030
Why?
Platinum
1
2012
58
0.030
Why?
Aorta, Abdominal
2
1990
60
0.030
Why?
Phenotype
1
2019
2226
0.030
Why?
Organ Sparing Treatments
1
2011
34
0.030
Why?
Length of Stay
1
1995
680
0.030
Why?
Supraglottitis
1
2011
3
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
183
0.030
Why?
Glutamates
1
2011
88
0.030
Why?
Leucovorin
1
2010
208
0.030
Why?
Clinical Trials, Phase I as Topic
1
2011
145
0.030
Why?
Antimetabolites, Antineoplastic
1
2012
240
0.030
Why?
Osteoradionecrosis
1
2010
14
0.030
Why?
Guanine
1
2011
200
0.030
Why?
Antineoplastic Agents, Phytogenic
1
2012
291
0.030
Why?
Interferon-alpha
1
2010
234
0.030
Why?
Postoperative Period
1
2010
300
0.020
Why?
Laryngoscopy
1
2009
36
0.020
Why?
Deoxycytidine
1
2011
225
0.020
Why?
Siblings
1
2010
102
0.020
Why?
Camptothecin
1
2010
193
0.020
Why?
Treatment Failure
1
2010
290
0.020
Why?
Dose-Response Relationship, Radiation
1
2009
199
0.020
Why?
Transforming Growth Factor alpha
1
2009
51
0.020
Why?
Postoperative Complications
1
1999
2189
0.020
Why?
Syndrome
1
2010
426
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
79
0.020
Why?
Chi-Square Distribution
1
2009
369
0.020
Why?
Bone Marrow Cells
1
2010
251
0.020
Why?
Arteriosclerosis
1
1988
158
0.020
Why?
Hypersensitivity
1
2009
140
0.020
Why?
Recombinant Proteins
1
2010
1021
0.020
Why?
Bacterial Infections
1
2010
222
0.020
Why?
Neoplasm Metastasis
1
2012
1021
0.020
Why?
Lymphatic Metastasis
1
2009
492
0.020
Why?
Regression Analysis
1
2009
599
0.020
Why?
Autoantibodies
1
2008
250
0.020
Why?
Cranial Sinuses
1
2006
13
0.020
Why?
Odds Ratio
1
2008
653
0.020
Why?
Blood Vessel Prosthesis
1
1988
223
0.020
Why?
Neoplasm Proteins
1
2010
529
0.020
Why?
Comorbidity
1
2009
894
0.020
Why?
Endothelium, Vascular
1
1988
426
0.020
Why?
Cerebrovascular Circulation
1
2006
208
0.020
Why?
Prevalence
1
2008
1220
0.020
Why?
Coronary Artery Disease
1
1988
355
0.020
Why?
Preoperative Care
1
2006
400
0.020
Why?
Signal Transduction
1
2014
3177
0.020
Why?
Algorithms
1
2011
1766
0.010
Why?
Registries
1
2006
659
0.010
Why?
Asthma
1
2009
851
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
57
0.010
Why?
Case-Control Studies
1
2006
1763
0.010
Why?
Ticarcillin
1
1999
2
0.010
Why?
Mouthwashes
1
1999
5
0.010
Why?
Ampicillin
1
1999
28
0.010
Why?
Administration, Topical
1
1999
95
0.010
Why?
Injections, Intravenous
1
1999
254
0.010
Why?
Infant
2
1996
3007
0.010
Why?
Child, Preschool
2
1996
3642
0.010
Why?
Pilot Projects
1
1999
798
0.010
Why?
Suspensions
1
1996
8
0.010
Why?
Animals
2
1994
26044
0.010
Why?
Bacteria
1
1999
451
0.010
Why?
Acute Disease
1
1996
833
0.010
Why?
Back Pain
1
1990
35
0.010
Why?
Hematoma
1
1990
91
0.010
Why?
6-Ketoprostaglandin F1 alpha
1
1988
6
0.010
Why?
Polytetrafluoroethylene
1
1988
69
0.010
Why?
Microscopy, Electron, Scanning
1
1988
155
0.010
Why?
Jugular Veins
1
1988
69
0.010
Why?
Omentum
1
1988
67
0.010
Why?
Microcirculation
1
1988
102
0.010
Why?
Dogs
1
1988
785
0.010
Why?
Aorta
1
1988
294
0.010
Why?
Thrombosis
1
1988
258
0.000
Why?
Blair's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_